Benziodarone is a uricostatic and a uricosuric agent which is sold also under the name Amplivex-Labaz. It is used in the treatment of gout A175630. It was withdrawn from France markets and British markets due to its effects causing Jaundice in patients T487, A175636.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Nitrofurantoin | The serum concentration of Nitrofurantoin can be increased when it is combined with Benziodarone. |
| Pegloticase | The risk or severity of adverse effects can be increased when Benziodarone is combined with Pegloticase. |
| Allopurinol | The excretion of Benziodarone can be increased when combined with Allopurinol. |
| Acetylsalicylic acid | The therapeutic efficacy of Benziodarone can be decreased when used in combination with Acetylsalicylic acid. |
| Methyclothiazide | The therapeutic efficacy of Benziodarone can be decreased when used in combination with Methyclothiazide. |
| Bendroflumethiazide | The therapeutic efficacy of Benziodarone can be decreased when used in combination with Bendroflumethiazide. |
| Benzthiazide | The therapeutic efficacy of Benziodarone can be decreased when used in combination with Benzthiazide. |
| Cyclothiazide | The therapeutic efficacy of Benziodarone can be decreased when used in combination with Cyclothiazide. |
| Hydroflumethiazide | The therapeutic efficacy of Benziodarone can be decreased when used in combination with Hydroflumethiazide. |
| Chlorothiazide | The therapeutic efficacy of Benziodarone can be decreased when used in combination with Chlorothiazide. |
| Hydrochlorothiazide | The therapeutic efficacy of Benziodarone can be decreased when used in combination with Hydrochlorothiazide. |
| Trichlormethiazide | The therapeutic efficacy of Benziodarone can be decreased when used in combination with Trichlormethiazide. |
| Polythiazide | The therapeutic efficacy of Benziodarone can be decreased when used in combination with Polythiazide. |
| Mebutizide | The therapeutic efficacy of Benziodarone can be decreased when used in combination with Mebutizide. |
| Cyclopenthiazide | The therapeutic efficacy of Benziodarone can be decreased when used in combination with Cyclopenthiazide. |
| Buthiazide | The therapeutic efficacy of Benziodarone can be decreased when used in combination with Buthiazide. |